Breast cancer
Computer enabled autofluorescence device for the diagnosis of breast lumps and determining completeness of surgical removal of breast tumours
Contact hospital
The registry names this hospital as the trial's main contact. Ask them which hospitals are taking patients.
Registry summary (technical)
Design and development of a machine learning enabled autofluorescence device for preoperative breast lump diagnosis and intraoperative breast tumor margin assessment - NIL
Sponsor: Indian Council of Medical Research
CTRI/2024/02/062338 on CTRI, India's trial registry
Source: Clinical Trials Registry – India (CTRI), via WHO ICTRP, data of 12 Oct 2026
Last updated on the registry 24 Jun 2025 · read by us 5 Nov 2026